SFC Fluidics, a leader in the development of innovative microfluidic drug delivery solutions, is proud to announce the launch of its newly redesigned website and a comprehensive brand refresh. This evolution reflects the company’s significant technical progress and its commitment to transforming the lives of patients through its PANDA™ and GEMINI™ System.
The updated digital presence, now live at sfc-fluidics.com, offers a streamlined, user-centric experience that mirrors the precision and elegance of the company's hardware.
Bridging Technology and Patient Care
As SFC Fluidics moves closer to commercial integration, the new platform highlights the versatility of its core technology across multiple therapeutic areas, including insulin delivery and beyond.
The newly launched digital platform provides researchers and partners with streamlined access to critical technical specifications and clinical applications. By integrating high-fidelity video and 3D renderings, the site offers an enhanced visual narrative of the PANDA drug delivery system, demonstrating its unique dual-pump mechanism and ultra-low-profile wearable design. These deep-dive technology insights showcase how SFC Fluidics achieves industry-leading dosing accuracy within a smaller, more efficient footprint, effectively bridging the gap between complex microfluidic engineering and real-world patient care.
"Our goal was to create a digital home that matches the caliber of our engineering," said Tony Cruz, CEO of SFC Fluidics "This isn't just a website update; it’s a reflection of our progress. We are moving from the lab to the real world, and our new brand identity signals that we are ready for the next chapter in precision medicine."